Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China flag China · Delayed Price · Currency is CNY
28.71
-0.40 (-1.37%)
At close: Feb 12, 2026

SHE:301584 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
1.622.222.562.231.330.12
Debt / EBITDA Ratio
5.276.327.317.054.550.60
Debt / FCF Ratio
3.3090.87----
Net Debt / Equity Ratio
0.811.211.521.310.75-0.43
Net Debt / EBITDA Ratio
2.853.774.754.572.80-2.18
Net Debt / FCF Ratio
1.6649.68-4.76-2.27-1.0065.49
Asset Turnover
-1.481.531.431.371.34
Inventory Turnover
-5.546.557.1610.8618.42
Quick Ratio
0.840.760.810.840.881.06
Current Ratio
1.171.121.121.131.141.19
Return on Equity (ROE)
-17.07%17.63%17.72%15.74%13.61%
Return on Assets (ROA)
-2.79%2.74%2.42%2.23%2.34%
Return on Invested Capital (ROIC)
10.59%10.41%10.20%11.19%16.28%27.16%
Return on Capital Employed (ROCE)
25.90%29.00%28.30%24.70%23.20%18.90%
Payout Ratio
42.39%66.53%68.06%81.68%89.32%62.13%
Buyback Yield / Dilution
0.28%0.05%-0.35%-0.14%-0.10%0.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.